TLR2 and acute myeloid leukemia: Further, to evaluate if the miR-23a-5p-TLR2-autophagy circuit can be used to predict the outcome in patients we correlated the expression of miR-23a-5p with prognosis (favorable risk, intermediate risk and adverse risk) in AML patients.